The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome

Carlioglu, Ayse; Kaygusuz, Ikbal; Karakurt, Feridun; Gumus, Ilknur; Uysal, Aysel; KASAPOĞLU, BENAN; Armutcu, Ferah; Uysal, Sema; Keskin, Esra; Koca, Cemile

doi:10.1007/s00404-014-3275-8

The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome

Copy For Citation

Carlioglu A., Kaygusuz I., Karakurt F., Gumus I. I., Uysal A., KASAPOĞLU B., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.290, no.5, pp.929-935, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 290 Issue: 5
Publication Date: 2014
Doi Number: 10.1007/s00404-014-3275-8
Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.929-935
Keywords: Polycystic ovary syndrome, Platelet activating factor acetyl hydrolyze, Oxidized LDL, Paraoxonase1, Paraoxonase1 phenotypes, Arylesterase, CORONARY-ARTERY-DISEASE, ACETYLHYDROLASE PAF-AH, INTIMA-MEDIA THICKNESS, RISK-FACTOR, CARDIOVASCULAR-DISEASE, INSULIN-RESISTANCE, HEART-DISEASE, CHRONIC INFLAMMATION, PHOSPHOLIPASE A(2), OXIDATIVE STRESS
Lokman Hekim University Affiliated: No

Abstract

Purpose To evaluate the platelet activating factor acetyl hydrolyze (PAF-AH), oxidized low-density lipoprotein (ox-LDL), paraoxonase 1 (PON1), arylesterase (ARE) levels and the effects of metformin and Diane-35 (ethinyl oestradiol + cyproterone acetate) therapies on these parameters and to determine the PON1 polymorphisms among PCOS patients.